Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ijgc.2025.101663 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Fundal Placenta Accreta: A Rare Presentation and Comprehensive Review.
Cureus
February 2025
Immunology, Immunopathology-Immunotherapy-Immunomonitoring Laboratory, Faculty of Medicine, Mohammed VI University of Health Sciences (UM6SS), Casablanca, MAR.
Fundal placenta accreta is a rare and challenging condition characterized by abnormal placental adherence to the myometrium, typically in the upper uterine segment. This case report describes a 35-year-old woman with a history of two previous cesarean sections, who presented at 19 weeks gestation with antepartum hemorrhage and was diagnosed with fundal placenta accreta. Diagnostic imaging, including ultrasound and MRI, revealed a centroplacental hematoma and signs of myometrial invasion, which were confirmed histopathologically after emergency extraction and postpartum management.
View Article and Find Full Text PDFRadical hysterectomy and ovarian transposition during cesarean section for newly diagnosed cervical cancer in pregnancy.
Int J Gynecol Cancer
January 2025
Fondazione Policlinico Universitario A. Gemelli, IRCCS, Dipartimento Scienze della Salute della Donna, del Bambino e di Sanità Pubblica, Unità Operativa Complessa di Ginecologia Oncologica, Rome, Italy; Università Cattolica del Sacro Cuore, Rome, Italy.
Evaluation of efficacy and fertility after nonradical surgical therapy (extra fascial hysterectomy or cone biopsy, with pelvic lymphadenectomy) for stage IA1, IA2, and IB1 cervical cancer (GOG-0278).
Gynecol Oncol
March 2025
Memorial Sloan Kettering Cancer Center, 1275 York Ave., New York, NY, United States of America. Electronic address:
Objective: To estimate the efficacy and perioperative morbidity of nonradical surgery (simple hysterectomy [SH] or cone biopsy [CB] plus pelvic lymphadenectomy [PLND] and to report pregnancy outcomes after CB.
Methods: Prospective international study with 3-year follow-up of patients with stage IA1 (lymphovascular space invasion-positive) to IB1 (≤2 cm) cervical cancer stratified by fertility preservation (CB) or none (SH) (both with PLND). Criteria included ≤10 mm stromal invasion and negative margins on loop electrosurgical excision procedure or CB.
SUCCOR 10 years: a decade's perspective on radical hysterectomy outcomes in cervical cancer.
Int J Gynecol Cancer
February 2025
Grigoriev Institute for Medical Radiology and Oncology, NAMS Ukraine, Kharkiv, Ukraine.
Objective: Interest in long-term outcomes of radical hysterectomy for cervical cancer has increased, especially after the LACC trial findings, which showed worse outcomes for minimally invasive surgery. However, limited information is available on 10-year oncological outcomes, particularly, recurrence and survival. The primary objective of this study was to analyze the 10-year oncological outcomes of patients with International Federation of Gynecology and Obstetrics 2009 stage IB1 cervical cancer treated with radical hysterectomy performed via minimally invasive or open approaches.
View Article and Find Full Text PDFRobotic trachelectomy with sentinel lymph node biopsy for cervical cancer: a prospective study investigating minimally invasive radicality.
Int J Clin Oncol
March 2025
Department of Obstetrics and Gynecology, Faculty of Medicine, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima, 890-8520, Japan.
Objective: The importance of minimally invasive fertility-sparing surgery for cervical cancer is gaining increasing interest, both to achieve a cure and for future fertility. Procedures for robotic radical trachelectomy involving uterine reconstruction are not fully established.
Methods: This study prospectively verified the feasibility and safety of robotic radical trachelectomy between February 2018 and May 2022.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!